Global Asthma Spacers Market Report and Forecast 2024-2032

Global Asthma Spacers Market Outlook

The global asthma spacers market size attained a value of USD 1.81 billion in 2023 driven by large asthmatic population, increase in government initiatives, rise in health care expenditure, rise in the number of production facilities, and widespread acceptance of pressurised metered-dose inhaler (MDI). The market is anticipated to grow at a CAGR of 5.1% during the forecast period of 2024-2032 to attain a value of USD 2.83 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Market Likely to be Driven by Spacers’ Usefulness in the Treatment of Asthma and Respiratory Disorders

Asthma is a key noncommunicable disease (NCD) affecting adults as well as children across the globe; it is caused due to inflammation and narrowing of minor airways present in the lungs, and may exhibit symptoms such as coughing, wheezing, shortness of breath and tightness in the chest.  Asthma is reported to have affected over 260 million people in 2019, and led to over 4,60,000 deaths. Among children, asthma is one of the most common chronic illnesses. However, with the help of inhaled medicine, asthma can be controlled and people suffering from the disorder may live an active and normal life.

Asthma spacers are hollow tubes (generally made of plastic) that may be attached to the mouthpiece of an inhaler on one end; a mouthpiece or mask on the other end enables the user to inhale the medicine released by the inhaler (when the inhaler is pressed, the medicine is released from the inhaler end, and inhaled by the user on the other end). Asthma spacers work best if used with a metered dose inhaler (MDI). Spacers are gaining significant popularity in the treatment of asthma through delivery of inhaled medicines. Spacers decrease issues associated with poor inhaler technique, and greatly reduce oral absorption of inhaled corticosteroids. In the treatment of acute asthma, spacers have been reported to give results as good as those provided by nebulisers. When used with a metered dose inhaler (MDI), spacers help users inhale the right amount of medicine into the lungs and prevent medicine wastage (spacers concentrate the medicine into a tube, preventing it from leaking into the air). Spacers prolong the amount of time taken for the medicine to pass into the lungs. This gives the person more time to inhale, so the medication can enter the lungs more effectively.

Spacers also make medicine inhalation easier. Spacers are particularly useful for kids, who may find using an inhaler otherwise difficult.

Increasing Variety of Spacers and their Use in Treatment of Respiratory Disorders Expected to Stimulate the Global Asthma Spacers Market

The different types of spacers available in the market include Volumatic, AeroChamber, Able Spacer, Space Chamber Plus, and A2A spacer. Disposable spacers (made of paper or plastic) are also available. However, these spacers can not be cleaned, and should not be used longer than suggested by the manufacturing company. The usefulness of spacers in the treatment of respiratory disorders, along with increased availability, is expected to boost the global asthma spacers market.

Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By spacer type, the market is segmented into:

• Volumatic
• Aerochamber
• InspirEase
• Optichamber
• Others

By distribution channel, the market is divided into:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By region, the market is classified into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Global Asthma Spacers Market

The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Trudell Medical International
• PARI Respiratory Equipment, Inc.
• Koninklijke Philips N.V
• GlaxoSmithKline Plc.
• Lupin
• Cipla Inc.
• Medical Developments International
• Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report